WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007089906) CATIONIC STEROID ANTIMICROBIAL COMPOSITIONS FOR TREATING OR PREVENTING HERPES INFECTIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/089906    International Application No.:    PCT/US2007/002793
Publication Date: 09.08.2007 International Filing Date: 31.01.2007
IPC:
A61K 31/56 (2006.01), A61K 31/568 (2006.01), A61K 31/57 (2006.01), A61K 31/575 (2006.01), A61K 45/06 (2006.01), A61P 31/16 (2006.01), G01N 33/15 (2006.01)
Applicants: BRIGHAM YOUNG UNIVERSITY [US/US]; 3760 HBLL, Provo, UT 84602-6844 (US) (For All Designated States Except US).
NATIONAL JEWISH MEDICAL AND RESEARCH CENTER [US/US]; 1400 Jackson Street, Denver, CO 80206 (US) (For All Designated States Except US).
SAVAGE, Paul, B. [US/US]; (US) (For US Only).
LEUNG, Donald [US/US]; (US) (For US Only)
Inventors: SAVAGE, Paul, B.; (US).
LEUNG, Donald; (US)
Agent: BEDGOOD, Robert, M.; PILLSBURY, WINTHROP SHAW PITTMAN, LLP, 12255 El Camino Real, Suite 300, San Diego, CA 92130-1593 (US)
Priority Data:
60/764,129 01.02.2006 US
Title (EN) CATIONIC STEROID ANTIMICROBIAL COMPOSITIONS FOR TREATING OR PREVENTING HERPES INFECTIONS
(FR) COMPOSITIONS ANTIMICROBIENNES STÉROÏDES CATIONIQUES ET MÉTHODES D'UTILISATION
Abstract: front page image
(EN)The invention provides methods for decreasing or inhibiting herpesviridae (HV) infection or pathogenesis of a cell in vitro, ex vivo or in vivo, a symptom or pathology associated with a herpesviridae (HV) infection or pathogenesis in vitro, ex vivo or in vivo, or an adverse side effect of herpesviridae (HV) infection or pathogenesis in vitro, ex vivo or in vivo. In one embodiment, a method of the invention includes treating a subject with an invention compound (e.g., cationic steroid antimicrobial or CSA).
(FR)Cette invention concerne des méthodes visant à réduire ou à inhiber une infection à Herpèsvirus (HV) ou la pathogenèse d'une cellule in vitro, ex vivo ou in vivo, un symptôme ou une pathologie associé à l'infection à Herpèsvirus (HV) ou la pathogenèse in vitro, ex vivo ou in vivo, ou un effet secondaire indésirable de l'infection à Herpèsvirus (HV) ou la pathogenèse in vitro, ex vivo ou in vivo. Dans un mode de réalisation, une méthode de cette invention consiste à traiter un sujet avec un composé de cette invention (tel qu'un antimicrobien stéroïde cationique ou CSA).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)